Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10222302 | Biological Psychiatry | 2018 | 50 Pages |
Abstract
[11C]-(+)-PHNO demonstrated high sensitivity to displacement by amphetamine-induced dopamine release, but dopamine release capacity and D2/D3 availability were not associated with ventral striatal activation to reward prediction error or clinical features, in this study powered to detect large effects. While a preponderance of indirect evidence implicates dopaminergic dysfunction in MDD, these findings suggest that presynaptic dopamine dysregulation may not be a feature of MDD or a prerequisite for treatment response to dopamine agonists.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Franklin R. Schneier, Mark Slifstein, Alexis E. Whitton, Diego A. Pizzagalli, Jenna Reinen, Patrick J. McGrath, Dan V. Iosifescu, Anissa Abi-Dargham,